Leadership Overview
ImpactLife has 4 executives leading key functions including strategy, financial oversight, human capital management, and clinical medical operations.
Dedicated to saving lives through blood donation, ImpactLife maintains a robust network of hospitals across the Midwest to ensure consistent access to life-saving blood products and essential medical services.
Dedicated to saving lives through blood donation, ImpactLife maintains a robust network of hospitals across the Midwest to ensure consistent access to life-saving blood products and essential medical services.
Leadership Roles at ImpactLife
Michael Parejko - Chief Executive Officer
Michael Parejko, the Chief Executive Officer at ImpactLife, directs the overarching strategic vision for the organization. Overseeing the entire operational footprint across Illinois, Iowa, Missouri, and Wisconsin, the Chief Executive Officer ensures the seamless delivery of blood products to partner hospitals. This leadership role involves constant collaboration with the Board to refine long-term growth objectives and maintain high standards of service excellence. By optimizing resource allocation and fostering community partnerships, Michael Parejko drives the mission of the organization forward. Parejko manages the complex logistics of blood collection and distribution, ensuring that the supply chain remains resilient against regional demand fluctuations. Through rigorous oversight of organizational performance, the Chief Executive Officer secures the stability of the blood supply network. Ultimately, Parejko maintains the operational integrity required to support critical healthcare needs throughout the Midwest region.
Darren Klocke - Chief Financial Officer
Darren Klocke, the Chief Financial Officer at ImpactLife, manages the fiscal health and economic sustainability of the organization. Overseeing all financial planning, budgeting, and capital investment strategies, the Chief Financial Officer ensures that resources align with the mission of providing blood products to hospitals. This leadership role involves monitoring revenue streams and controlling operational costs to maximize the impact of every donation. By implementing robust financial controls, Darren Klocke protects the long-term viability of the organization. Klocke collaborates with executive leadership to evaluate the financial feasibility of new service expansions across the Midwest. Through precise financial reporting and risk management, the Chief Financial Officer maintains transparency and accountability. Ultimately, Klocke secures the necessary funding to support the infrastructure required for blood collection and processing, ensuring that the organization remains a reliable partner for healthcare providers in the region.
Jennifer Feeney - Chief People Officer
Jennifer Feeney, the Chief People Officer at ImpactLife, directs the human capital strategy and organizational culture initiatives. Overseeing talent acquisition, employee development, and workforce engagement, the Chief People Officer ensures that the staff remains equipped to handle the demands of the blood services industry. This leadership role involves designing programs that attract and retain skilled professionals across the regional footprint. By fostering a culture of excellence and safety, Jennifer Feeney drives high performance throughout the organization. Feeney collaborates with other executives to align workforce capabilities with the evolving needs of hospitals in Illinois, Iowa, Missouri, and Wisconsin. Through the implementation of comprehensive training and wellness initiatives, the Chief People Officer supports the well-being of the entire team. Ultimately, Feeney builds a resilient workforce capable of sustaining the critical mission of the organization in a fast-paced healthcare environment.
Daniela Hermelin - Chief Medical Officer
Daniela Hermelin, the Chief Medical Officer at ImpactLife, directs the clinical standards and medical safety protocols for all blood products. Overseeing the medical oversight of blood collection and transfusion services, the Chief Medical Officer ensures compliance with rigorous healthcare regulations across the Midwest. This leadership role involves guiding the clinical team to maintain the highest quality of care for patients in partner hospitals. By integrating medical research and best practices, Daniela Hermelin drives innovation in blood banking services. Hermelin collaborates with the executive team to address complex medical challenges and improve transfusion outcomes. Through the continuous monitoring of clinical performance and safety metrics, the Chief Medical Officer upholds the reputation of the organization as a trusted medical partner. Ultimately, Hermelin ensures that every blood product meets the necessary safety standards to support life-saving medical procedures throughout the regional service area.
Explore Leadership Teams in Blood & Organ Banks
Carter BloodCare is an independent, community blood center providing transfusion resources. Services include collection, processing, specialized laboratory testing, storage and distribution of blood and blood products. The program is accredited by the AABB, including a laboratory with accreditation for molecular testing of red cell antigens. It is licensed by the U.S. Food and Drug Administration and is a member of America's Blood Centers.
Company Leadership NJ

SP
TH
Vitalant is a national community blood service provider, supplying comprehensive transfusion medicine services for hospitals and health care partners for patients in need. Vitalant inspires local communities to serve the needs of others and transform lives through the selfless act of donating blood.
Company Leadership MF

KC
PE
Novavax, Inc. is a biotechnology company incorporated in 1987 and headquartered in Gaithersburg, Maryland, focused on discovering, developing, and commercializing vaccines to protect against serious infectious diseases. The company's proprietary technology platform combines a recombinant protein approach, nanoparticle technology, and a patented adjuvant to enhance immune response. Novavax's pipeline spans vaccine candidates targeting infectious diseases including COVID-19, influenza, respiratory syncytial virus, malaria, shingles, and other pathogens, with ongoing exploration of its adjuvant platform in oncology. The company maintains a strategic partnership with Sanofi for COVID-19 vaccine commercialization and has established licensing and collaboration agreements with major global pharmaceutical companies. Novavax trades on the NASDAQ under the ticker symbol NVAX.
Company Leadership JJ
RM


Established in 1975, the Gulf Coast Regional Blood Center is headquartered in Houston, Texas. They serve more than 170 hospitals and healthcare institutions in the Texas Gulf Coast, Brazos Valley, and East Texas regions.
Company Leadership
SR
DM
DG